Join our Community
Support ToI and remove all ads
Learn more
×

European Medicines Agency

A woman looks on, as a health worker prepares to administer a booster shot of Pfizer COVID-19 vaccine at a community health center in Jakarta, Indonesia, on January 12, 2022. (AP Photo/ Dita Alangkara)
January 12, 2022, 10:20 am
EU regulator skeptical on need for additional COVID booster shot
As Israel administers fourth dose of vaccine to the elderly and immunosuppressed, EMA official says move likely ineffective
By Ethan Freedman
A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic in Jerusalem, September 1, 2021. (Olivier Fitoussi/ Flash90)
October 4, 2021, 8:19 pm
EU drug agency gives green light to COVID vaccine booster for adults
European Medicines Agency rules to approve 3rd shots of Pfizer-BioNTech’s coronavirus inoculation for all people aged over 18
By AP and ToI Staff
A syringe is prepared with the Pfizer COVID-19 vaccine at a clinic at the Reading Area Community College in Reading, Pennsylvania, September 14, 2021. (AP Photo/Matt Rourke, File)
September 23, 2021, 8:13 pm
EU drug agency to decide on COVID boosters in weeks
European Medicines Agency will rule in early October if to approve 3rd shots of the Pfizer coronavirus vaccine for all people aged over 16
By AFP and ToI Staff
A vial of the Pfizer vaccine for COVID-19 in Seattle, January 24, 2021. (Ted S. Warren/AP)
May 28, 2021, 10:12 pm
EU regulator green lights Pfizer vaccine for 12- to 15-year-olds
Decision by European Medicines Agency must still be okayed by European Commission before countries get go-ahead to start giving COVID shots to adolescents
By AP
Vials of the Comirnaty vaccine by Pfizer-BioNTech at the Allergopharma production facilities in Reinbek, near Hamburg, northern Germany, April 30, 2021. (Christian Charisius / POOL / AFP)
May 3, 2021, 7:50 pm
EU drug agency starts evaluating Pfizer vaccine for 12- to 15-year olds
European Medicines Agency says it will carry out ‘accelerated assessment of data’ on shot when submitted by its producers
By AFP and ToI Staff
Medical staff prepare an AstraZeneca coronavirus vaccine during preparations at the vaccine center in Ebersberg near Munich, Germany, March 22, 2021. (Matthias Schrader/AP)
April 7, 2021, 7:04 pm
EU: Possible AstraZeneca link to rare blood clots; UK: Offer under 30s a choice
European Medicines Agency insists that the benefits of inoculation against COVID-19 from the shot outweigh the dangers; UK health body changes its policies on offering its use
By Agencies
Vials of the AstraZeneca COVID-19 vaccine in a fridge at the local vaccine center in Ebersberg near Munich, Germany, March 22, 2021. (Matthias Schrader/AP)
April 1, 2021, 12:26 am
Despite rare blood clot fears, EU backs continued use of AstraZeneca vaccine
European Medicines Agency says there is ‘no evidence’ to support restricting use of shots against coronavirus, even though Germany has banned its administration to those below 60
By Frank Jordans
A person enters the European Medicines Agency in Amsterdam, Netherlands, Dec. 21, 2020, where the EMA's human medicines committee is holding an exceptional, fully virtual, meeting to conclude the evaluation of the Pfizer-BioNTech COVID-19 vaccine. (AP Photo/Peter Dejong)
December 21, 2020, 1:57 pm
EU regulator meets to discuss approval of Pfizer’s COVID-19 vaccine
If scientists conclude inoculation is safe, officials are expected to give conditional approval for it to be used across the 27-nation bloc
By AP
Illustrative. A syringe and a bottle reading 'COVID-19 Vaccine' next to the Pfizer company logo, November 23, 2020. (JOEL SAGET / AFP)
December 1, 2020, 1:36 pm
Pfizer, BioNTech ask Europe to approve coronavirus vaccine
Companies say shot, if authorized for use, could be rolled out before end of year; German science minister says safety standards are being maintained
By Agencies and ToI Staff
Load More
Sign in or Join The Times of Israel Community
Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.